Followers | 9845 |
Posts | 260028 |
Boards Moderated | 4 |
Alias Born | 12/27/2006 |
Thursday, June 04, 2020 5:54:04 PM
Link to Video - click here to watch the technical chart video
Recent KZR News
- Kezar Life Sciences to Present at the H.C. Wainwright 26th Annual Global Investment Conference • Business Wire • 09/04/2024 08:01:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/13/2024 08:10:54 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/13/2024 08:05:42 PM
- Kezar Life Sciences Reports Second Quarter 2024 Financial Results and Provides Business Update • Business Wire • 08/13/2024 08:02:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/26/2024 09:41:02 PM
- Kezar Announces Inducement Grant Under NASDAQ Listing Rule 5635(c)(4) • Business Wire • 07/10/2024 08:01:00 PM
- Kezar Announces Inducement Grant Under NASDAQ Listing Rule 5635(c)(4) • Business Wire • 06/07/2024 09:59:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/04/2024 08:30:33 PM
- Kezar Life Sciences to Participate in the Jefferies Global Healthcare Conference • Business Wire • 05/29/2024 08:01:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/09/2024 08:08:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/09/2024 08:04:53 PM
- Kezar Life Sciences Reports First Quarter 2024 Financial Results and Provides Business Update • Business Wire • 05/09/2024 08:01:00 PM
- Kezar Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) • Business Wire • 05/06/2024 08:05:00 PM
- Kezar Announces Inducement Grant Under NASDAQ Listing Rule 5635(c)(4) • Business Wire • 04/08/2024 08:01:00 PM
- Kezar Life Sciences Reports Fourth Quarter and Year End 2023 Financial Results and Provides Business Update • Business Wire • 03/14/2024 08:01:00 PM
- Kezar Announces Inducement Grant Under NASDAQ Listing Rule 5635(c)(4) • Business Wire • 03/08/2024 09:05:00 PM
- Kezar Life Sciences to Participate in the TD Cowen 44th Annual Health Care Conference • Business Wire • 02/28/2024 09:01:00 PM
- Everest Medicines and Kezar Life Sciences Receive IND Approval from China NMPA for PALIZADE Trial in Lupus Nephritis • Business Wire • 02/26/2024 11:30:00 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/14/2024 11:50:01 AM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 01/17/2024 10:09:43 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/09/2024 09:56:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/08/2024 01:36:27 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/04/2023 09:28:24 PM
- Kezar Life Sciences to Present at the 6th Annual Evercore ISI HealthCONx Conference • Business Wire • 11/21/2023 09:01:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/13/2023 09:13:05 PM
North Bay Resources Commences Operations at Bishop Gold Mill, Inyo County, California; Engages Sabean Group Management Consulting • NBRI • Sep 25, 2024 9:15 AM
CEO David B. Dorwart Anticipates a Bright Future at Good Gaming Inc. Through His Most Recent Shareholder Update • GMER • Sep 25, 2024 8:30 AM
Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • BLOZF • Sep 24, 2024 8:50 AM
Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • INTV • Sep 24, 2024 8:45 AM
Avant Technologies Accelerates Creation of AI-Powered Platform to Revolutionize Patient Care • AVAI • Sep 24, 2024 8:00 AM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM